Bracco Company Profile

What is the competitive landscape for BRACCO, and what generic alternatives to BRACCO drugs are available?

BRACCO has forty approved drugs.

There are three US patents protecting BRACCO drugs.

There are thirty-seven patent family members on BRACCO drugs in twelve countries and seventy-four supplementary protection certificates in eight countries.

Summary for Bracco

International Patents:	37
US Patents:	3
Tradenames:	64
Ingredients:	32
NDAs:	40

Drugs and US Patents for Bracco

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bracco	E-Z-PAQUE	barium sulfate	FOR SUSPENSION;ORAL	208036-002	Apr 7, 2017		RX	Yes	Yes
Bracco	ISOVUE-250	iopamidol	INJECTABLE;INJECTION	020327-002	Oct 12, 1994		DISCN	Yes	No
Bracco	PROHANCE	gadoteridol	INJECTABLE;INJECTION	020131-001	Nov 16, 1992		RX	Yes	Yes
Bracco	MULTIHANCE	gadobenate dimeglumine	INJECTABLE;INTRAVENOUS	021357-002	Nov 23, 2004		RX	Yes	Yes
Bracco	THALLOUS CHLORIDE TL 201	thallous chloride tl-201	INJECTABLE;INJECTION	018548-001	Dec 30, 1982		DISCN	No	No
Bracco	CHOLOGRAFIN SODIUM	iodipamide sodium	INJECTABLE;INJECTION	009321-001	Approved Prior to Jan 1, 1982		DISCN	No	No

Expired US Patents for Bracco

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bracco	PROHANCE	gadoteridol	INJECTABLE;INJECTION	020131-001	Nov 16, 1992	4,885,363
Bracco	KINEVAC	sincalide	INJECTABLE;INJECTION	017697-001	Approved Prior to Jan 1, 1982	6,803,046
Bracco	CARDIOTEC	technetium tc-99m teboroxime kit	INJECTABLE;INJECTION	019928-001	Dec 19, 1990	6,056,941
Bracco	CARDIOGEN-82	rubidium chloride rb-82	INJECTABLE;INJECTION	019414-001	Dec 29, 1989	4,562,829
Bracco	PROHANCE	gadoteridol	INJECTABLE;INJECTION	020131-001	Nov 16, 1992	5,474,756
Bracco	ISOVUE-250	iopamidol	INJECTABLE;INJECTION	020327-002	Oct 12, 1994	4,001,323

International Patents for Bracco Drugs

Country	Patent Number	Estimated Expiration
Singapore	11202010539R
Canada	3137089
Japan	2022532344
Japan	2021529730
Japan	7148742
South Korea	102556398

Supplementary Protection Certificates for Bracco Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0806968	SPC/GB07/011	United Kingdom		PRODUCT NAME: GADOFOSVESET TRISODIUM; REGISTERED: UK EU/1/05/313/001 20051003; UK EU/1/05/313/002 20051003; UK EU/1/05/313/003 20051003; UK EU/1/05/313/004 20051003; UK EU/1/05/313/005 20051003; UK EU/1/05/313/006 20051003; UK EU/1/05/313/007 20051003; UK EU/1/05/313/008 20051003; UK EU/1/05/313/009 20051003
1948158	1690020-1	Sweden		PRODUCT NAME: SACUBITRIL AND VALSARTAN, AS SACUBITRIL VALSARTAN SODIUM SALT COMPLEX, I.E. TRISODIUM 3-((1S,3R)-1-BIPHENYL-4-YLMETHYL-3- ETHOXYCARBONYL-1-BUTYLCARBAMOYL)PROPIONATE-(S)-3-METHYL-2- (PENTANOYL2-(TETRAZOL-5-YLATE)BIPHENYL-4- YLMETHYLAMINO)BUTYRATE HEMIPENTAHYDRATE; REG. NO/DATE: EU/1/15/1058 20151123
2563920	CA 2019 00001	Denmark		PRODUCT NAME: A COMPOUND COMPRISING A MODIFIED OLIGONUCLEOTIDE HAVING A NUCLEOBASE SEQUENCE CONSISTING OF 20 LINKED NUCLEOSIDES ACCORDING TO EP B1 2563920 CLAIM 1 (SEQ ID NO: 80), ...SPECIFICALLY INOTERSEN; AND ITS DERIVATIVES, INCLUDING SODIUM SALTS ...; REG. NO/DATE: EU/1/18/1296 20180710
1556389	SPC/GB16/002	United Kingdom		PRODUCT NAME: CEFTOLOZANE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IN PARTICULAR A SULFURIC ACID SALT.; REGISTERED: UK EU/1/15/1032 20150922
2822954	2018/031	Ireland		PRODUCT NAME: BICTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR BICTEGRAVIR SODIUM.; REGISTRATION NO/DATE: EU/1/18/1289 20180625
2203431	92666	Luxembourg		PRODUCT NAME: DASABUVIR OU UN SEL QUI EN DERIVE, Y COMPRIS DASABUVIR SODIUMMONOHYDRATE. FIRST REGISTRATION: 20150119

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Bracco